tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

XENE Stock Latest News

Xenon Pharmaceuticals price target raised to $66 from $60 at Stifel
The FlyXenon Pharmaceuticals price target raised to $66 from $60 at Stifel
3d ago
XENE
Xenon Pharmaceuticals Issues Inducement Stock Options to New Hires
PremiumCompany Announcements
Xenon Pharmaceuticals Issues Inducement Stock Options to New Hires
28d ago
XENE
Xenon Pharmaceuticals: Undervalued ‘Pipeline-in-a-Drug’ Story with Blockbuster Potential Ahead of Key 2026 Readouts
PremiumRatings
Xenon Pharmaceuticals: Undervalued ‘Pipeline-in-a-Drug’ Story with Blockbuster Potential Ahead of Key 2026 Readouts
1M ago
XENE
Xenon Pharmaceuticals: Advancing Late-Stage Epilepsy and Depression Programs and Expanding NaV1.7/Kv7 Pipeline Support Buy Rating and $55 Target
PremiumRatings
Xenon Pharmaceuticals: Advancing Late-Stage Epilepsy and Depression Programs and Expanding NaV1.7/Kv7 Pipeline Support Buy Rating and $55 Target
1M ago
XENE
Xenon Sets 2026–2027 Milestone Timetable for Azetukalner and Pain Pipeline
PremiumCompany Announcements
Xenon Sets 2026–2027 Milestone Timetable for Azetukalner and Pain Pipeline
1M ago
XENE
Xenon Pharmaceuticals outlines key upcoming milestones
PremiumThe FlyXenon Pharmaceuticals outlines key upcoming milestones
1M ago
XENE
Xenon Pharmaceuticals price target raised to $62 from $60 at JPMorgan
Premium
The Fly
Xenon Pharmaceuticals price target raised to $62 from $60 at JPMorgan
1M ago
XENE
Xenon to Showcase Neuroscience Pipeline at J.P. Morgan Healthcare Conference
Premium
Company Announcements
Xenon to Showcase Neuroscience Pipeline at J.P. Morgan Healthcare Conference
1M ago
XENE
Xenon Pharmaceuticals: Strategic Advancements and Promising Clinical Results Justify Buy Rating
PremiumRatings
Xenon Pharmaceuticals: Strategic Advancements and Promising Clinical Results Justify Buy Rating
2M ago
XENE
Xenon’s Promising Epilepsy Treatment and Strategic Growth Potential Drive Buy Rating
PremiumRatings
Xenon’s Promising Epilepsy Treatment and Strategic Growth Potential Drive Buy Rating
2M ago
XENE
Xenon Pharmaceuticals Unveils Promising Long-Term Epilepsy Treatment Data
PremiumCompany Announcements
Xenon Pharmaceuticals Unveils Promising Long-Term Epilepsy Treatment Data
2M ago
XENE
Xenon announces new data on 48-month azetukalner OLE study data
PremiumThe Fly
Xenon announces new data on 48-month azetukalner OLE study data
2M ago
XENE
Xenon Pharmaceuticals Issues Equity Inducement Grants to New Employees
PremiumCompany AnnouncementsXenon Pharmaceuticals Issues Equity Inducement Grants to New Employees
2M ago
XENE
Xenon Pharmaceuticals to Host Webinar on Epilepsy Data and Commercialization Plans
Premium
Company Announcements
Xenon Pharmaceuticals to Host Webinar on Epilepsy Data and Commercialization Plans
2M ago
XENE
Xenon Expands 2025 Equity Incentive Plan
Premium
Company Announcements
Xenon Expands 2025 Equity Incentive Plan
2M ago
8K
XENE
Xenon Pharmaceuticals to Present New Epilepsy Research at AES 2025
PremiumCompany Announcements
Xenon Pharmaceuticals to Present New Epilepsy Research at AES 2025
3M ago
XENE
Xenon Pharmaceuticals price target raised to $60 from $57 at JPMorgan
PremiumThe Fly
Xenon Pharmaceuticals price target raised to $60 from $57 at JPMorgan
3M ago
XENE
Xenon Pharmaceuticals to Present at Key Investor Conferences
PremiumCompany Announcements
Xenon Pharmaceuticals to Present at Key Investor Conferences
3M ago
XENE
Xenon Pharmaceuticals’ Earnings Call Highlights Optimism and Progress
PremiumCompany Announcements
Xenon Pharmaceuticals’ Earnings Call Highlights Optimism and Progress
3M ago
XENE
Xenon Pharmaceuticals price target raised to $58 from $55 at RBC Capital
PremiumThe FlyXenon Pharmaceuticals price target raised to $58 from $55 at RBC Capital
3M ago
XENE
Xenon Pharmaceuticals price target lowered to $44 from $48 at Wells Fargo
Premium
The Fly
Xenon Pharmaceuticals price target lowered to $44 from $48 at Wells Fargo
3M ago
XENE
Xenon Pharmaceuticals: Promising Drug Pipeline and Market Potential Drive Buy Rating
Premium
Ratings
Xenon Pharmaceuticals: Promising Drug Pipeline and Market Potential Drive Buy Rating
3M ago
XENE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >